文献速递神经肿瘤

成人IDH突变型脑干胶质瘤的临床结局、影像学表现与遗传特征

Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults.
PubMed 文献 · Acta Neurochir (Wien) · 2024-06-12

该回顾性研究分析了2006至2022年间北海道大学医院12例经组织病理学证实的成人脑干胶质瘤患者,其中4例存在IDH突变。所有患者均接受54 Gy/27次局部放疗联合替莫唑胺化疗。IDH突变型患者中位无进展生存期68.4个月、总生存期85.2个月,均长于IDH野生型的5.6个月和12.0个月。

要点

  • 12例成人脑干胶质瘤中4例检出IDH突变,包括IDH1 R132H三例和IDH2 R172G一例。
  • IDH突变型中位无进展生存期68.4个月、总生存期85.2个月,长于IDH野生型的5.6个月和12.0个月。
  • 作者认为对成人脑干胶质瘤应积极考虑活检以明确基因型。

核心结论

  • 部分成人脑干胶质瘤存在IDH突变,且预后与IDH野生型明显不同,作者主张积极考虑活检以确认基因型。

研究设计与样本

  • 回顾性分析2006年至2022年北海道大学医院收治的成人脑干胶质瘤患者资料,评估患者特征、治疗方法、遗传特征及预后。
  • 12例经组织病理学证实的脑干胶质瘤患者中,4例鉴定为IDH突变。

主要发现

  • 4例IDH突变患者均接受54 Gy/27次局部放疗联合替莫唑胺化疗。
  • 3例为IDH1 R132H突变,1例为IDH2 R172G突变。
  • IDH突变型中位无进展生存期68.4个月、中位总生存期85.2个月,IDH野生型分别为5.6个月和12.0个月。
  • 初始起病时,4例IDH突变患者中2例在磁共振成像上可见对比增强病灶。

临床怎么用

  • 作者认为,由于部分成人脑干胶质瘤存在IDH突变且预后与IDH野生型明显不同,应积极考虑活检以确认基因型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the recent advent of genetic testing, IDH-mutant glioma has been found among adult brainstem gliomas. However, the clinical outcome and prognosis of IDH-mutant brainstem gliomas in adults have not been elucidated. This study aimed to investigate the clinical outcome, radiological findings, and genetic features of adult patients with IDH-mutant diffuse brainstem gliomas. METHODS: Data from adult patients with brainstem glioma at Hokkaido University Hospital between 2006 and 2022 were retrospectively analyzed. Patient characteristics, treatment methods, genetic features, and prognosis were evaluated. RESULTS: Of 12 patients with brainstem glioma with proven histopathology, 4 were identified with IDH mutation. All patients underwent local radiotherapy with 54 Gray in 27 fractions combined with chemotherapy with temozolomide. Three patients had IDH1 R132H mutation and one had IDH2 R172G mutation. The median progression-free survival and overall survival were 68.4 months and 85.2 months, respectively, longer than that for IDH-wildtype gliomas (5.6 months and 12.0 months, respectively). At the time of initial onset, contrast-enhanced lesions were observed in two of the four cases in magnetic resonance imaging. CONCLUSION: As some adult brainstem gliomas have IDH mutations, and a clearly different prognosis from those with IDH-wildtype, biopsies are proactively considered to confirm the genotype.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Oki S, Ishi Y, Sawaya R, et al. Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults. Acta Neurochir (Wien). 2024. PMID: 38864949. doi:10.1007/s00701-024-06154-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。